UK and Australia give OK to Ranbaxy's Paonta Sahib plant
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories' Paonta Sahib manufacturing facility in India, which is currently under US FDA scrutiny for quality violations, has received GMP certificates from the UK's MHRA and Australia's Therapeutic Goods Administration (TGA).